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did not screen for these enzymes. Respondents
from the MYSTIC survey were more likely to
screen for ESBLs, and were more concerned about
the incidence of ESBL-producing bacteria than
respondents from the omnibus survey. This is not
surprising, as participants in surveillance studies
may be more aware of the issue of antimicrobial
resistance, which may be their initial reason for
enrolling in a surveillance study.
In both surveys, many participants who
screened for ESBLs did not identify them further,
either because it was thought unnecessary, or
because of lack of funding or facilities. Identifica-
tion of the particular type of ESBL that a resistant
organism produces will reveal the antibiotic
resistance profile of the organism and may help
clinicians to choose the most appropriate therapy
[7]. Where high prevalences of ESBL producers
are demonstrated as a result of surveillance
studies or screening, an appropriate initial empir-
ical therapy that covers ESBL-producing strains
should be considered. The double-disk synergy
test was the most common test used to detect
ESBLs in both surveys, but the Etest ESBL screen
was thought to be the most efficacious method.
The most appropriate screening methodology
should therefore be determined locally, according
to local resources.
Overall, the surveys demonstrated that aware-
ness of, and testing for, ESBLs is inconsistent.
Since ESBLs have an influence on morbidity and
mortality, and are associated with clinical failure,
it is important to increase the level of awareness
and frequency of testing for ESBLs.
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A B S T R A C T
Two oxacillin disk methods were compared with
a cefoxitin disk diffusion test for detection of
methicillin-resistant Staphylococcus aureus (MRSA),
with PCR for mecA as the reference method. When
tested with 115 MRSA and 350 methicillin-sus-
ceptible S. aureus isolates, the cefoxitin disk test
(specificity 100%, sensitivity 96.5%) was superior
to the oxacillin disk methods (specificity 99.1%,
sensitivity 90.4%). Testing with both oxacillin and
cefoxitin disks would give better sensitivity
(100%) than the cefoxitin test alone, but at the
expense of specificity (99.1%). The cefoxitin disk
test required no special test conditions and would
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improve the reliability of routine tests for detec-
tion of MRSA.
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Methicillin-resistant Staphylococcus aureus (MRSA)
have become increasingly prevalent worldwide.
Rapid and accurate identification of MRSA is
required to help clinicians select appropriate anti-
biotic treatment and to avoid the spread of these
strains [1–8]. However, there is no optimal phen-
otypic method for detecting methicillin resistance
in S. aureus [2,8–10], and genotypic tests involving
mecA gene detection by PCR, which are considered
to be the reference [11–13], are not practical for
routine use in clinical laboratories. Thus, there
remains a need for a reliable test for MRSA that
can be performed easily in routine situations. In
this context, the use of cefoxitin rather than
oxacillin for disk tests has been advocated [3–5].
Therefore, the present study compared the per-
formance of disk diffusion tests with cefoxitin
and oxacillin disks for the detection of MRSA.
In total, 465 isolates of S. aureus were obtained
from individual patients in 2001 and 2002 at two
Tunisian teaching hospitals. The isolates were
identified by conventional methods (Gram-posit-
ive cocci, catalase-positive, mannitol-fermenting
and DNase-positive), and were confirmed as
S. aureus by their ability to coagulate rabbit
plasma (bioMe´rieux, Marcy l’Etoile, France) and
produce clumping factor (Staphyslide test; bio-
Me´rieux). Isolates were characterised as MRSA or
methicillin-susceptible S. aureus (MSSA) follow-
ing DNA extraction with the InstaGene Matrix
(Bio-Rad Laboratories, Marnes La Coquette,
France) and PCR for the mecA gene with primers
MEC1 (5¢-AAAATCGATGGTAAAGGTTGGC-3¢)
and MEC2 (5¢-AGTTCTGCAGTACCGCATTT-
GC-3¢) [14]. Amplification was performed with
a GeneAmp PCR System 2400 (Perkin-Elmer,
Norwalk, CT, USA) with 50 lL of reaction buffer
containing 5 lL of bacterial DNA extract, 200 lM
of each dNTP, 2.5 mM MgCl2, 20 pmol of each
primer and 0.5 U of AmpliTaq polymerase
(Promega, Lyon, France).
Oxacillin susceptibility testing was performed
with 5-lg oxacillin disks incubated at 30C for
24 h on Mueller–Hinton agar, and with 5-lg
oxacillin disks incubated at 37C for 24 h on
Mueller–Hinton agar supplemented with NaCl
4% w ⁄v, in accordance with the guidelines of the
Comite´ de l’Antibiogramme de la Socie´te´ Franc¸-
aise de Microbiologie (CA-SFM) [15]. Susceptibil-
ity to cefoxitin was determined without the
special conditions used for oxacillin testing [15].
A suspension of organisms adjusted to 0.5·
MacFarland standard was diluted 1:100 and
inoculated on to Mueller–Hinton agar by streak-
ing over the agar surface. Cefoxitin 30-lg disks
were applied and the plates were incubated at
37C for 24 h. An isolate was considered to be an
MRSA strain if the cefoxitin inhibition zone
diameter was £ 21 mm [3]. S. aureus strains ATCC
43300 (heterogeneous oxacillin resistance) and
ATCC 25923 (oxacillin-susceptible) were used as
quality control strains.
Of the 465 isolates tested, 115 were
mecA-positive by PCR, and 350 were negative
(Table 1). The two oxacillin disk methods with
Mueller–Hinton agar incubated at 30C, and with
Mueller-Hinton agar supplemented with NaCl
4% w ⁄ v incubated at 37C, agreed with each
other, but falsely identified 11 isolates as oxacillin-
susceptible (sensitivity 90.4%) and three isolates
as oxacillin-resistant (specificity 99.1%) in com-
parison with PCR. The cefoxitin disk test detected
oxacillin resistance correctly in all but four
isolates (sensitivity 96.5%), and there were no
false-resistant results (specificity 100%). The 11
resistant isolates reported as susceptible by the
oxacillin method were different from the four
Table 1. Susceptibility of Staphylo-
coccus aureus isolates tested with two
oxacillin disk diffusion methods and
a cefoxitin disk diffusion method in













Negative 350 350 0 347 3
Positive 115 4 111 11 104
aBoth oxacillin disk methods used (see Materials and methods) gave identical results.
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resistant isolates reported as susceptible by the
cefoxitin method. Hence, in total, there were 18
discordant results (three with MSSA and 15 with
MRSA) between the oxacillin disk methods and
the cefoxitin disk method. Combining the results
of tests with both cefoxitin and oxacillin would
give a sensitivity of 100% and a specificity of
99.1%. The greater reliability of tests with cefox-
itin disks confirmed earlier studies which showed
that cefoxitin disk tests, without modification to
conditions to improve expression of resistance,
are as reliable or more reliable than oxacillin disk
tests for the detection of methicillin resistance in
S. aureus [3–5].
Methicillin resistance in S. aureus is associated
with the production of an altered penicillin-
binding protein, PBP2a, encoded by the mec
gene complex [8,10]. Laboratory methods have
been developed to enhance the expression of
methicillin resistance in staphylococci by modi-
fications to test conditions, including supple-
mentation of media with NaCl and prolonging
the incubation period to 24 h. Phenotypic meth-
ods for detecting MRSA remain controversial
[12,16,17], and MRSA strains are not always
identified correctly. Problems in detection of
MRSA may be caused by low-level expression of
oxacillin resistance in some strains [12,16,17].
One study that included heterogeneous strains
found that disk diffusion methods had low
sensitivity [8]. There are also difficulties in
differentiating MRSA from borderline oxacillin-
resistant S. aureus (BORSA) strains [10,18]. As
shown in this and other studies, no phenotypic
method is completely reliable for the detection
of MRSA [2,6,8,10,12,19].
Errors in the detection of oxacillin resistance
can have serious adverse clinical consequences
[9]. False-susceptibility results may result in
treatment failure and the spread of MRSA if
appropriate infection control measures are not
applied. Conversely, false-resistance results may
increase health care costs following unnecessary
isolation precautions, and may lead to overuse of
glycopeptides [20]. Hence, accurate identification
of MRSA is necessary. Detection of the mecA
gene (or PBP2a) is recognised to be the most
accurate method for detecting methicillin resist-
ance in S. aureus [10,13]. However, use of PCR
assays is generally limited to specialised refer-
ence laboratories, and neither method is used
widely for routine methicillin susceptibility tests
in diagnostic laboratories. The cefoxitin disk
susceptibility test appeared to be a useful proce-
dure in that it is easy to perform in routine
laboratories and has greater accuracy than oxa-
cillin disk tests. Combining the results of cefox-
itin and oxacillin tests would improve the
sensitivity of the cefoxitin test alone, but the
specificity would be reduced. The cefoxitin disk
test has the potential for wider use in diagnostic
laboratories.
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A B S T R A C T
Cerebrospinal fluid (CSF) concentration–time
curves of rifampicin and fusidic acid were studied
in a patient with post-operative meningitis caused
by Staphylococcus epidermidis. The patient was
treated with this combination of antimicrobial
agents because of a severe hypersensitivity reac-
tion to vancomycin. Peak CSF concentrations of
rifampicin exceeded the MIC by > 60-fold, while
those of fusidic acid just reached the MIC. CSF
concentrations of fusidic acidwere relatively stable
within the range reported for patients with unin-
flamed meninges, but serum levels were surpris-
ingly low. An increase in the metabolism of fusidic
acid induced by rifampicin cannot be excluded.
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Data on the pharmacokinetics of rifampicin and
fusidic acid in cerebrospinal fluid (CSF) are
limited. Therefore, it was of interest to study the
drug concentration–time curves in a patient with
post-operative ventricular drain-associated Sta-
phylococcus epidermidis meningitis. The patient
was treated with this combination because of a
severe hypersensitivity reaction to vancomycin,
which is used commonly for the treatment of
post-surgical nosocomial meningitis [1,2].
The patient was a 55-year-old man with a
massive sub-arachnoid haemorrhage and acute
hydrocephalus. The aneurysm was embolised and
CSF drainage was started. Three weeks later, the
patient developed meningitis. The CSF showed
marked pleocytosis and yielded an isolate of
S. epidermidis that was resistant to all antibiotics
tested except vancomycin, rifampicin and fusidic
acid. Despite ventricular catheter removal and
treatment with intravenous vancomycin for
1 week, the patient’s condition deteriorated. A
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